Literature DB >> 26211680

Phosphodiesterase 4D: an enzyme to remember.

Roberta Ricciarelli1, Ernesto Fedele2.   

Abstract

Cyclic adenosine monophosphate (cAMP) is one of the second messengers critically involved in the molecular mechanisms underlying memory formation. In the CNS, the availability of cAMP is tightly controlled by phosphodiesterase 4 (PDE4), a family of enzymes that degrades the cyclic nucleotide to inactive AMP. Among the different PDE4 isoforms, in the last few years PDE4D has been hogging the limelight due to accumulating evidence for its crucial role in cognitive processes, which makes this enzyme a promising target for therapeutic interventions in a variety of pathological conditions characterized by memory impairment, such as Alzheimer's disease. In this article, we review the role of the cAMP signal transduction pathway in memory formation with a particular focus on the recent progress in PDE4D research.
© 2015 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26211680      PMCID: PMC4621991          DOI: 10.1111/bph.13257

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  60 in total

Review 1.  The late maintenance of hippocampal LTP: requirements, phases, 'synaptic tagging', 'late-associativity' and implications.

Authors:  Klaus G Reymann; Julietta U Frey
Journal:  Neuropharmacology       Date:  2006-08-21       Impact factor: 5.250

2.  RNA interference-mediated phosphodiesterase 4D splice variants knock-down in the prefrontal cortex produces antidepressant-like and cognition-enhancing effects.

Authors:  Zhen-Zhen Wang; Yi Zhang; Yan-Qin Liu; Nan Zhao; You-Zhi Zhang; Li Yuan; Lei An; Jing Li; Xiao-Yun Wang; Juan-Juan Qin; Steven P Wilson; James M O'Donnell; Han-Ting Zhang; Yun-Feng Li
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

3.  Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect.

Authors:  J A Cherry; R L Davis
Journal:  J Comp Neurol       Date:  1999-05-03       Impact factor: 3.215

4.  Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis.

Authors:  Annette Robichaud; Panagiota B Stamatiou; S-L Catherine Jin; Nicholas Lachance; Dwight MacDonald; France Laliberté; Susana Liu; Zheng Huang; Marco Conti; Chi-Chung Chan
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

5.  Overexpression of type-1 adenylyl cyclase in mouse forebrain enhances recognition memory and LTP.

Authors:  Hongbing Wang; Gregory D Ferguson; Victor V Pineda; Paige E Cundiff; Daniel R Storm
Journal:  Nat Neurosci       Date:  2004-05-09       Impact factor: 24.884

6.  Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice.

Authors:  Kris Rutten; Dinah L Misner; Melissa Works; Arjan Blokland; Thomas J Novak; Luca Santarelli; Tanya L Wallace
Journal:  Eur J Neurosci       Date:  2008-08       Impact factor: 3.386

7.  Inhibition of protein kinase A activity interferes with long-term, but not short-term, memory of conditioned taste aversions.

Authors:  Ming Teng Koh; Todd E Thiele; Ilene L Bernstein
Journal:  Behav Neurosci       Date:  2002-12       Impact factor: 1.912

8.  A family of cAMP-binding proteins that directly activate Rap1.

Authors:  H Kawasaki; G M Springett; N Mochizuki; S Toki; M Nakaya; M Matsuda; D E Housman; A M Graybiel
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

9.  RNA interference-mediated knockdown of long-form phosphodiesterase-4D (PDE4D) enzyme reverses amyloid-β42-induced memory deficits in mice.

Authors:  Cong Zhang; Yufang Cheng; Haitao Wang; Chuang Wang; Steven P Wilson; Jiangping Xu; Han-Ting Zhang
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

10.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

View more
  9 in total

1.  Male-Specific cAMP Signaling in the Hippocampus Controls Spatial Memory Deficits in a Mouse Model of Autism and Intellectual Disability.

Authors:  Marta Zamarbide; Adele Mossa; Pablo Muñoz-Llancao; Molly K Wilkinson; Heather L Pond; Adam W Oaks; M Chiara Manzini
Journal:  Biol Psychiatry       Date:  2018-12-27       Impact factor: 13.382

2.  Associations between SNP83 of phosphodiesterase 4D gene and carotid atherosclerosis in a southern Chinese Han population: a case-control study.

Authors:  Liu-Yu Liu; Dong-Can Mo; Jian-Li Li; Yi-Ying Jiang; Guo-Qiu Zhou; Dong-Dong Jiang; Li-Jie Chen; Xiao-Ju Wu; Jiao-Xing Li; Man Luo
Journal:  Mamm Genome       Date:  2021-03-23       Impact factor: 2.957

Review 3.  Phosphodiesterase 4D: an enzyme to remember.

Authors:  Roberta Ricciarelli; Ernesto Fedele
Journal:  Br J Pharmacol       Date:  2015-09-22       Impact factor: 8.739

4.  Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target.

Authors:  Thavy Long; Liliana Rojo-Arreola; Da Shi; Nelly El-Sakkary; Kurt Jarnagin; Fernando Rock; Maliwan Meewan; Alberto A Rascón; Lin Lin; Katherine A Cunningham; George A Lemieux; Larissa Podust; Ruben Abagyan; Kaveh Ashrafi; James H McKerrow; Conor R Caffrey
Journal:  PLoS Negl Trop Dis       Date:  2017-07-13

5.  Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer's disease.

Authors:  Roberta Ricciarelli; Chiara Brullo; Jos Prickaerts; Ottavio Arancio; Carla Villa; Claudia Rebosio; Elisa Calcagno; Matilde Balbi; Britt T J van Hagen; Elentina K Argyrousi; Hong Zhang; Maria Adelaide Pronzato; Olga Bruno; Ernesto Fedele
Journal:  Sci Rep       Date:  2017-04-12       Impact factor: 4.379

6.  Rheb Inhibits Beiging of White Adipose Tissue via PDE4D5-Dependent Downregulation of the cAMP-PKA Signaling Pathway.

Authors:  Wen Meng; Xiuci Liang; Hongzhi Chen; Hairong Luo; Juli Bai; Guangdi Li; Qinghai Zhang; Ting Xiao; Sijia He; Yacheng Zhang; Zhipeng Xu; Bo Xiao; Meilian Liu; Fang Hu; Feng Liu
Journal:  Diabetes       Date:  2017-02-27       Impact factor: 9.461

7.  Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer's disease.

Authors:  Chen Zhang; Qian Zhou; Xu-Nian Wu; Ya-Dan Huang; Jie Zhou; Zengwei Lai; Yinuo Wu; Hai-Bin Luo
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

Review 8.  Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches.

Authors:  Amy J Tibbo; Gonzalo S Tejeda; George S Baillie
Journal:  Biochem Soc Trans       Date:  2019-10-31       Impact factor: 5.407

Review 9.  Memory Enhancers for Alzheimer's Dementia: Focus on cGMP.

Authors:  Ernesto Fedele; Roberta Ricciarelli
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.